![Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? | The Pharmacogenomics Journal Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? | The Pharmacogenomics Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41397-019-0078-0/MediaObjects/41397_2019_78_Fig1_HTML.png)
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? | The Pharmacogenomics Journal
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO g
![PDF) Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in large cell neuroendocrine carcinoma PDF) Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in large cell neuroendocrine carcinoma](https://i1.rgstatic.net/publication/313412293_Evaluation_of_the_efficacy_of_cisplatin-etoposide_and_the_role_of_thoracic_radiotherapy_and_prophylactic_cranial_irradiation_in_large_cell_neuroendocrine_carcinoma/links/5ad349330f7e9b285934f059/largepreview.png)
PDF) Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in large cell neuroendocrine carcinoma
![Carcinoma colorettale: linee di ricerca, innovazioni e sfide future. Congresso a Pisa - insalutenews.it Carcinoma colorettale: linee di ricerca, innovazioni e sfide future. Congresso a Pisa - insalutenews.it](https://www.insalutenews.it/in-salute/wp-content/uploads/2016/06/prof-alfredo-falcone-direttore-polo-oncologico-aoup-e1574425631425.png)
Carcinoma colorettale: linee di ricerca, innovazioni e sfide future. Congresso a Pisa - insalutenews.it
![Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a9d53b31-f719-4a73-9368-5af7d2d8be2b/gr1.jpg)
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del
![PDF) Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest | Gianluca Tomasello - Academia.edu PDF) Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest | Gianluca Tomasello - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/76814430/mini_magick20211219-27607-ynt4yq.png?1639901477)
PDF) Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest | Gianluca Tomasello - Academia.edu
![Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer | Request PDF Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer | Request PDF](https://i1.rgstatic.net/publication/349031046_Clinical_significance_of_enterocyte-specific_gene_polymorphisms_as_candidate_markers_of_oxaliplatin-based_treatment_for_metastatic_colorectal_cancer/links/601d5b5ba6fdcc37a80610e5/largepreview.png)
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer | Request PDF
Biosimilar pegfilgrastim and adherence to guidelines for chemotherapy-induced neutropenia and infections in cancer patients
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorec
![Frontiers | Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial | Oncology Frontiers | Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial | Oncology](https://www.frontiersin.org/files/Articles/925366/fonc-12-925366-HTML/image_m/fonc-12-925366-g001.jpg)